Review article: Symptom improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 6, 1996, Pages 843-850

  Laheij, R J F ^a,c   Jansen, J B M J ^a   Van De Lisdonk, E H ^b   Severens, J L ^b   Verbeek, A L M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c MIES ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL INFECTION; DYSPEPSIA; ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL;

EID: 0029801485     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.86258000.x     Document Type: Article

References (89)

1. Talley NJ. A critique of therapeutic trails in Helicobacter ter pylori-positive functional dyspepsia. Gastroenterology 1994; 106: 1174-83.
2. Veldhuyzen van Zanten SJO, Sherman PM. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and non-ulcer dyspepsia: a systematic overview. Can Med Assoc J 1994; 150(2): 177-85.
3. Q'Connor HJ. Eradication of Helicobacter pylori: therapies and clinical implications. Postgrad Med J 1992; 68: 549-57.
4. Veldhuyzen van Zanten SJO. A systematic overview (meta-analysis) of outcome measures in Helicobacter pylori gastritis trails and functional dyspepsia. Scand J Gastroenterol 1995; 28(Suppl. 199): 40-3.
5. Miettinen OS. Theoretically Epidemiology, Principals of Occurrence Research in Medicine. New York: Delmar publishing, 1985.
6. Alvisi V, Laterza A, Caberletti I, et al. Is amoxicillin effective in Campylobacter pylori-associated inflammatory gastroduodenal pathology. In: Megraud F, ed. Gastroduodenal Pathology and Campylobacter pylori. Amsterdam, Elsevier Science, 1989; 575-80.
7. Bamford KM, Collins JSA, Collins BJ, et al. Amoxycillin and colloidal bismuth subcitrate improve associated gastritis but not symptoms in patients with non-ulcer dyspepsia. Klin Wochenschr 1989; 67 (Suppl.): 3.
8. Barbara L, Biasco G, Capurso L, et al. Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia. Am J Gastroenterol 1990; 85: 1109-13.
9. Barberis C, Lamouliatte H, Demascarel A, et al. Controlled study of amoxicillin in Campylobacter pylori associated gastritis. In: Megraud F, ed. Gastroduodenal Pathology and Campylobacter pylori. Amsterdam, Elsevier Science, 1989.
10. Bayerdorffer E. Double-blind treatment of early gastric malt-lymphoma patients by Helicobacter pylori eradication. Am J Gastroenterol 1994; 89: 1355.
11. Bertschinger P, Brunner J, Flury R, et al. Vergeleich der Wirksamkeit von omeprazol/bismutsubcitrat oder tripletherapie bei Helicobacter pylori gastritis. Schweiz Med Wochenschr 1992; 122: 1446-51
12. Bona M, Laurino L, Doglioni C, Bellumat A, Boni de M. Eradication of Helicobacter pylori and resolution of gastritis. Acta Gastroenterol Belg 1993; 56 (Suppl.): 69.
13. Borody TJ, Carrick J. Long-term Campylobacter pylori recurrence following apparent eradication. In: Megraud F, ed. Gastro-duodenal Pathology and Campylobacter pylori. Amsterdam: Elsevier Science, 1989: 591-3.
14. Borody TJ, Andrews P, Shortis NP, Huskamp K, Leube C. Non-ulcer dyspepsia sub-groups and therapy for Helicobacter pylori. Am J Gastroenterol 1994; 89: 321.
15. Buiatti E. Monoz N, Vivas J, et al. Difficulty in eradicating Helicobacter pylori in a population at high risk for stomach cancer in Venezuela. Cancer Causes Control 1994; 5: 249-54.
16. Catalane F, Terranova R, Brogna A, et al. Hp positive functional dyspepsia in elderly patients: comparison of two treatments. Gastroenterology 1995; 108: A67(Abstract).
17. Catalano F, Branciforte G, Liberte A, et al. Non-ulcer dyspepsia Helicobacter pylori postive patients. Acta Gastroenterol Belg 1993; 56 (Suppl.): 132.
18. Ching CK, Thompson S, Buxton C, Holgate C. Holmes GKT. Evaluate of a commercial enzyme-linked immunosorbent (ELISA) kit for serological diagnosis of Helicobacter pylori infection in a group of non-ulcer dyspepsia. Postgrad Med J 1993; 69: 456-60.
19. Coppola FV, Boero MG, Recchia S, Verme G. Campylobacter pylori in antral gastritis: therapeutic response to CBS versus ranitidine. In: Megraud F, ed. Gastroduodenal Pathology and Campylobacter pylori. Amsterdam: Eisevier Science, 1989: 587-90.
20. Daskalopoulos G, Carrick J, Lian R, Lee A. Optimising therapy for Helicobacter pylori gastritis. Irish J Med Sci 1992; 161: 16.
21. Dill S, Payne-James JJ, Misiewics JJ, et al. Evaluation of C-urea breath test in the detection of Helicobacter pylori and in monitoring the effect of tripotassium dicitratobismuthate in non-ulcer dyspepsia. Gut 1990; 31: 1237-41.
22. Elta GH, Scheiman JM, Barnett JL, et al. Long term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. Am J Gastroenterol 1995; 90: 1089-93.
23. Elta GH, Murphy R, Behler EM, et al. Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion. Am J Gastroenterol 1989; 84: 643-6.
24. Ferrari APJ, Geocze S, Lanzoni VPB, et al. Use of ampicillin plus ranitidine for Helicobacter pylori gastritis. Brazil J Med Biol Res 1991; 24: 567-72.
25. Frazzoni M, Lonardo A, Grisendi A, et al. Are routine duodenal and antral biopsies useful in the management of functional dyspepsia. J Clin Gastroenterol 1993; 17: 101-8.
26. Gad A, Dobrilla G. Campylobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol 1989; 24 (Suppl. 167): 39-43.
27. Gilvarry J, Buckley M, Beattie, Hamiton H, O'Morain C. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Acta Gastroenterol Belg 1993; 56 (Suppl.): 49.
28. Glupczynski Y, Burette A, Labbe M, et al. Campylobacter pylori associated gastritis a double blind placebo controlled trail with amoxycillin. Am J Gastroenterol 1988; 83: 365-72.
29. Glupczynski Y, Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment. Am J Gastroenterol 1990; 85: 98-9.
30. Goh KL, Parasakthi N, Peh SC, et al. Helicobacter pylori infection and non-ulcer dyspepsia. Scand J Gastroenterol 1991; 26: 1123-31.
31. Goh KL, Wong NW, Parasakthi N, et al. Treatment of Helicobacter pylori associated non-ulcer dyspepsia with combination therapy of collidal bismuth subcitrate and antibiotics. Gastroenterology 1991; 100: A72(Abstract).
32. Holcombe C, Thom C, Kaluba J, Lucas SB. Helicobacter pylori in the aetiology of non-ulcer dyspepsia. Gut 1989; 30: A564(Abstract).
33. Holcombe C, Thom C, Kaluba J, Lucas SB. Helicobacter pylori clearance in the treatment of non-ulcer dyspepsia. Aliment Pharmacol Ther 1992; 6: 119-23.
34. Kang JY, Tay HH, Wee A, et al. Effect of effect colloide bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. Gut 1990; 31: 476-80.
35. Kazi JI, Jafarey NA, Alam SM, et al. A placebo controlled trail of bismuth salicylate in Helicobacter pylori associated gastritis. J Pakistan Med Assoc 1990; 40: 154-6.
36. Khanna MU, Abraham P, Nair NG, Mistry FP, Vora IM. Colloidal bismuth subcitrate in non-ulcer dyspepsia. J Postgrad Med 1992; 38: 106-8.
37. Koelz HR, Blum AL. Therapeutic response in functional dyspepsia is independent of infection with Helicobacter pylori and its supression. Acta Gastroenterol Belg 1993; 56 (Suppl.): 73.
38. Korwin JD de, Joubert M, Bazin N, et al. Lansoprazole versus lansoprazole plus antibiotics in the treatment of Helicobacter pylori gastric infection. Irish J Med Sci 1992; 161: 15.
39. Korwin JD, Forestier B. Symptomactic improvement correlated with Helicobacter pylori clearance after treatment with diosmectite in non-ulcus dyspepsia. Acta Gastroenterol Belg 1993; 56 (Suppl.): 149.
40. Lambert JR, Dunn K, Borromeo M, Korman MG. Hansky J. Campylobactyer pylori - a role in non-ulcur dyspepsia. Scand J Gastroenterol 1989; 160 (Suppl.): 7-13.
41. Lamouliatte H, Megraud F, De Mascarel A, et al. Does omeprazole improve amoxycillin therapy directed towards Campylobacter pylori associated chronic gastritis. Klin Wochenschr 1989; 67 (Suppl.): 37.
42. Lanza FL, Skoglund ML, Rack MF, Yardley JH. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled randomized study. Am J Gastroenterol 1989; 84: 1060-4.
43. Loffeld RJLF, Potters HVJP, Stobberingh E. et al. Campylobacter associated gastritis in patients with non-ulcer dyspepsia a double blind placebo controlled trial with colloidal bismuth subcitrate. Gut 1989; 30: 1206-12.
44. Marshall BJ, Valenzuela JE, McCallum RW, et al. Bismuth subsalicylate suppression of Helicobacter pylori in non ulcer dyspepsia. Dig Dis Sci 1993; 38: 1674-80.
45. Marshall BJ, Hoffman SR, McCallum RW. Incidence of side effects during bismuth subsalicylate and antibiotic therapy for Helicobacter pylori. Gastroenterology 1991; 100: A117(Abstract).
46. McCarthy C, Patchett S, Collins RM, et al. Long term effect of Helicobacter pylori eradication in non-ulcer dyspepsia. Gastroenterology 1991; 11: A212(Abstract).
47. McCarthy C, Patchett S, Collins RM, et al. Long term prospective study of Helicobacter pylori in non-ulcer dyspepsia. Dig Dis Sci 1995; 40: 114-9.
48. McColl KEL, Fullarton GM, Nujumi AME, et al. Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer. Lancet 1989; 334: 499-500.
49. McNulty CAM, Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori. Rev Infect Dis 1990; 12: S94-8.
50. McNulty CAM, Gearty JC, Crump B, et al. Campylobacter pyloridis and associated gastritis: investigator blind placebo controlled trail of bismuth salicylate and erythromycin ethylsuccinate. Br Med J 1986;293:645-9.
51. Mertens JCC, Dekker W, Ligtvoet EEJ, Blok P. Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia. Antmicrob Agent Chemother 1989; 33: 256-7.
52. Morgan D, Kraft W, Bender M, Pearson A. Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. Gastroenterology 1988; 95: 1178-84.
53. Nafeeza MI, Shahimi MM, Kudva MV, et al Evaluation of therapies in the treatment of Helicobacter pylori associated non-ulcer dyspepsia. Singapore Med J 1992; 33: 570-4.
54. Napoli AD, Petrino R, Boero M, Chiandussi L. Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobactyer pylori. J Clin Pathol 1992; 45: 796-8.
55. Neri M. Eradication of Helicobacter pylori and improvement of Helicobacter pylori gastritis after combined treatments with omeprazole bismuth and clarithromycin. Acta Gastroenterol Belg 1993; 56 (Suppl.): 142.
56. Neri M, Susi D, Laterza F, et al. Omeprazole, bismuth and clarithromycin in the sequential treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1994; 8: 469-71.
57. Ozmen MM, Patankar RS, Johnson CD. The effect of Helicobacter pylori eradication on symptom relief in patients with functional dyspepsia. Gastroenterology 1995; 108 (Suppl.): A997(Abstract).
58. O'Morain C. Helicobacter pylori and non-ulcer dyspepsia. Gastroenterology 1992; 103: 340-1.
59. Patchett S, Beattie S, Leen E, Keane C, O'Morain C. Eradicating Helicobacter pylori and symptoms of non ulcer dyspepsia. Br Med J 1991; 303: 1238-40.
60. Petrino R, Napoli AD, Boero M, et al. Cure of chronic dyspepsia with eradication of Helicobacter pylori infection. Ital J Gastroenterol 1991; 23 (Suppl.): 78.
61. Pretolani S, Bonnvicini F, Brocchi E, et al. Non-ulcer dyspepsia: Is there any correlation between clinical symptoms and histophatological features. Ital J Gastroenterol 1991; 23 (Suppl.): 80.
62. Rauws EAJ. Long-term follow-up of Campylobacter pylori-associated gastritis after treatment with CBS and/or amoxicillin. In: Megraud F, ed. Gastroduodenal Pathology and Campylobacter pylori. Amsterdam: Elsevier Science, 1990.
63. Rocha GA. Dulciene MD, Queiroz M, et al. Helicobacter pylori acute gastritis: histological endoscopical, clinical and therapeutic features. Am J Gastroenterol 1991; 86: 1592-5.
64. Rokkas T, Pursey C, Uzoechina E, et al. Non-ulcer dyspepsia and short term de-Nol therapy a placebo controlled trial with particular reference to the role of Campylobacter pylori. Gut 1988; 29: 1386-91.
65. Sabbatini F, Gastiglione F, Piai G, et al. The long-term outcome of dyspeptic patients after Helicobacter pylori. Gastroenterology 1994; 104: A182(Abstract).
66. Safe AF, Warren B, Corfield A, et al. Role of serology in monitoring treatment for Helicobacter pylori infection in elderly patients. Age Aging 1993; 22: 256-9.
67. Stanescu A, Gabard B, Draggici A, et al. Bismuthcitrate/ amoxicillin a new galenic formulation for Helicobacter pylori eradication. Acta Gastroenterol Belg 1993; 56 (Suppl.): 145.
68. Stanescu A, Malfertheiner P, Mayer D, Baczako K, Ditschuneit H. Wismutaluminate in der gastroenterologie. Fortschr Med 1989; 107: 623-6.
69. Stone J, Wise R, Donovan IA, Gearty J. Failure of ciprofloxacin to eradicate Campylobacter pylori from the stomach. J Antimicrob Chemother 1988; 22: 92-3.
70. Talley NJ, Ormand JO, Carpenter HA, Phillips SF. Triple therapy for Helicobacter pylori in nonulcer dyspepsia. Gastroenterology 1991; 86: 121-2.
71. Thurmer HL, Flaaten B, Erichsen K, Solheim SB. Helicobacter pylori eradication improves symptoms and reduces costs in non ulcer dyspepsia patients. Scand J Gastroenterol 1995; 30 (Suppl.): FF28.
72. Timothy T, Schubert M, Ford H. Non-ulcer dyspepsia symptoms and Helicobacter pylori. Rev Esp Enferm Dig 1990; 78 (Suppl.): P145.
73. Trespi E, Broglia F, Villani L, et al. Distinct profiles of gastritis in dyspepsia subgroups. Scand J Gastroenterol 1994; 29: 884-8.
74. Unge P, Gad A, Gnarpe H, Olsson J. Does omeprazole improve antimicrobial therapy direct towards gastric Campylobacter pylori in patients with antral gastritis. Scand J Gastroenterol 1989; 24 (Suppl.): 49-54.
75. Varia D, Holton J, Cairns SR, et al. Antibody titres to Campylobacter pylori after treatment for gastritis. Br Med J 1988; 297: 5.
76. Varia D, Holton J, Falzon M, et al. The benefit of treating dyspeptic patients with normal endoscopic appearances. Rev Esp Enferm Digest 1990; 78 (Suppl. 1): P229.
77. Vaira D, Holton J, Ainley C. Double blind trail of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. Ital J Gastroenterol 1992; 24: 400-4.
78. Varia D, Miglioli M, Ferrieri A, et al. The role of rifaximin in eradicating Helicobacter pylori infection. Acta Gastroenterol Belg 1993; 56 (Suppl.): 147.
79. Veenendaal RA. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991; 32: 1291-4.
80. Veldhuyzen van Zanten S, Malatjalian D, Tanton R, et al. The effect of eradication of Helicobacter pylori on symptoms of non-ulcer dyspepsia: a randomised double blind placebo controlled trial. Gastroenterology 1995; 108: A250(Abstract).
81. Wagner S, Varrentrapp M, Haruma K, et al. The role of omeprazole in the treatment of gastric Helicobacter pylori infection. Z Gastroenterol 1991; 29: 595-8.
82. Wagner S, Bleck J, Gabel M, Bar W, Manns M. What treatment is best for gastric Helicobacter pylori infection. Irish J Med Sci 1992; 161: 16.
83. Westblom TU, Double blind randomized trail of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection. Scand J Gastroenterol 1992; 27: 249-52.
84. Witteman EM, Hopman WPM, Becx MCJM, et al. Acquisition of metronidazole resistance in patients with Helicobacter pylori related gastritis. Acta Gastroenterol Belg 1993; 56 (Suppl.): 65.
85. Witteman EM. Helicobacter pylori-associated gastritis and functional dyspepsia. In: Clinical and pathophysical aspects of eradication of Hp. PhD thesis. University of Nijmegen. 1994.
86. Xiao SD, Liu WZ, Xia DH. The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter pylori. Hepatogastroenterology 1990; 37: 503-6.
87. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991; 13: 42-59.
88. Wilhelmsen I, Haug TT, Sipponen P, Berstad A. Helicobacter pylori in functional dyspepsia and normal controls. Scand J Gastroenterol 1994; 29: 522-7.
89. Schlemper RJ, Sjoerd D, Werf I van der, et al. Non-ulcer dyspepsia in a Dutch working population and Helicobacter pylori. Arch Intern Med 1995; 155: 82-7.